Remission of HIV-related naïve and high-risk Burkitt’s lymphoma treated by autologous stem cell transplantation plus cART

Abstract A 27-year-old male with HIV-associated naïve and high-risk Burkitt’s lymphoma sequentially received short-term, high-dose non-myeloablative chemotherapy and autologous CD34-positive stem cell transfusion in the setting of combined antiretroviral therapy (cART). Prompt hematopoietic recovery...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Haiyan Min, Jianwei Yang, Sanbin Wang, Pengfei Tao, Yuqin Song, Xiaopei Wang, Huiqin Li, Xinping Yang, Xingqi Dong, Fu-Sheng Wang, Ming Shi, Xicheng Wang, Ruonan Xu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2018-12-01
Serie:	Stem Cell Research & Therapy
Soggetti:	HIV Naïve Burkitt’s lymphoma Autologous stem cell transplantation Antiretroviral therapy CD4+T
Accesso online:	http://link.springer.com/article/10.1186/s13287-018-1089-5
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!